Literature DB >> 8862842

Perioperative problems in Parkinson's disease and their management: apomorphine with rectal domperidone.

N Gálvez-Jiménez1, A E Lang.   

Abstract

OBJECTIVE: To present guidelines on the use of apomorphine in combination with rectal domperidone in Parkinson's disease (PD) patients undergoing abdominal surgery and to review the perioperative problems encountered in such patients.
BACKGROUND: PD patients undergoing abdominal surgery present a major therapeutic challenge. Because most antiparkinsonian medications must be withheld until the patient is able to resume oral intake, resulting rigidity and akinesia as well as alterations in gastrointestinal motility, respiratory function and swallowing mechanisms predispose these patients to numerous serious postoperative complications. We have found that parenteral apomorphine in combination with rectal domperidone markedly facilitates the care of these difficult patients.
METHODS: Presentation of two illustrative cases with review of the literature.
RESULTS: A standardized protocol using subcutaneous apomorphine and rectal domperidone was used in two PD patients who underwent abdominal surgery. Excellent control of parkinsonian symptomatology was obtained without side effects. The simplicity of the protocol was emphasized in our second patient who required urgent reoperation; the surgery nursing staff was able to restart the apomorphine immediately without having to wait for neurological follow-up assessment.
CONCLUSIONS: The use of parenteral apomorphine with rectal domperidone in the immediate postoperative period for patients unable to take oral antiparkinson drugs increases patient comfort, facilitates nursing care and may reduce serious postoperative complications.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8862842     DOI: 10.1017/s0317167100038518

Source DB:  PubMed          Journal:  Can J Neurol Sci        ISSN: 0317-1671            Impact factor:   2.104


  12 in total

1.  Case report: successful use of rectally administered levodopa-carbidopa.

Authors:  S D Cooper; H A Ismail; C Frank
Journal:  Can Fam Physician       Date:  2001-01       Impact factor: 3.275

2.  [Intermittent apomorphine injections as rescue therapy for advanced Parkinson's disease. Consensus statement].

Authors:  C Trenkwalder; S Boesch; A Ceballos-Baumann; D Dressler; K Eggert; T Gasser; H Honig; T Müller; H Reichmann; J P Sieb; A Storch; P Odin; W Poewe
Journal:  Nervenarzt       Date:  2008-04       Impact factor: 1.214

3.  Rotigotine transdermal system for perioperative administration.

Authors:  A D Korczyn; H Reichmann; B Boroojerdi; H-J Häck
Journal:  J Neural Transm (Vienna)       Date:  2006-12-21       Impact factor: 3.575

4.  Successful perioperative management of patients with Parkinson's disease following gastrointestinal surgery: report of three cases.

Authors:  Takaaki Fujii; Toshihiro Nakabayashi; Shinji Hashimoto; Hiroyuki Kuwano
Journal:  Surg Today       Date:  2009-09-24       Impact factor: 2.549

5.  Intravenous amantadine is safe and effective for the perioperative management of patients with Parkinson's disease.

Authors:  Young Eun Kim; Han-Joon Kim; Ji Young Yun; Beom S Jeon
Journal:  J Neurol       Date:  2011-05-06       Impact factor: 4.849

Review 6.  [Apomorphine in the treatment of Parkinson's Disease].

Authors:  D Dressler
Journal:  Nervenarzt       Date:  2005-06       Impact factor: 1.214

7.  Inpatient management of Parkinson disease: current challenges and future directions.

Authors:  Odinachi Oguh; Aleksandar Videnovic
Journal:  Neurohospitalist       Date:  2012-01

8.  Subcutaneous apomorphine in late stage Parkinson's disease: a long term follow up.

Authors:  K Pietz; P Hagell; P Odin
Journal:  J Neurol Neurosurg Psychiatry       Date:  1998-11       Impact factor: 10.154

Review 9.  [Perioperative management of patients with Parkinson's disease].

Authors:  J Spiegel
Journal:  Orthopade       Date:  2009-09-03       Impact factor: 1.087

Review 10.  Clinical problems in the hospitalized Parkinson's disease patient: systematic review.

Authors:  Oliver H H Gerlach; Ania Winogrodzka; Wim E J Weber
Journal:  Mov Disord       Date:  2011-01-31       Impact factor: 10.338

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.